Feb 26, 2009 - Genzyme Corporation today announced that the U.S. FDA has granted marketing approval for Synvisc-One™ (hylan G-F 20), a product intended for the relief of pain associated with osteoarthritis (OA) of the knee.
The details can be read here.
No comments:
Post a Comment